Embolism and thrombosis of saphenous vein (greater) (lesser) ICD-10-CM Alphabetical Index References for 'I82.81 - Embolism and thrombosis of superficial veins of lower extremities' The ICD-10-CM Alphabetical Index links the below-listed medical terms to the ICD code I82.81. Click on any term below to browse the alphabetical index.
However, when the thrombosis occurs outside of the varicose vein or in a vein in which there is no stagnant blood flow, other causes should be though of. Historically saphenous vein thrombosis was regarded as a benign condition.
Short description: Embolism and thrombosis of superficial veins of r low extrem The 2022 edition of ICD-10-CM I82.811 became effective on October 1, 2021. This is the American ICD-10-CM version of I82.811 - other international versions of ICD-10 I82.811 may differ.
To date there is no clear recommendation as to the treatment of saphenous vein thrombosis. The latest ACCP guidelines suggests 45 days of prophylactic dose fondaparinux for ‘extensive’ lower extremity thrombosis. They are relying on the CALISTO study.
The occurrence of associated deep venous thrombosis and pulmonary embolism is variable. Varicose veins- The great saphenous vein is a superficial vein. The deep veins (posterior tibial, anterior tibial, fibular, popliteal, femoral) are separated from the superficial veins by a series of valves.
Background: Isolated great saphenous vein thrombus (GSVT) is generally regarded as benign, and treatment is heterogeneous. Complications include thrombus propagation, new saphenous vein thrombosis, deep vein thrombosis (DVT), pulmonary embolism (PE), and symptom persistence.
Great Saphenous Vein (GSV) – The GSV is the large superficial vein of the leg and the longest vein in the entire body. It can be found along the length of the lower limb, returning blood from the thigh, calf, and foot to the deep femoral vein at the femoral triangle. The femoral triangle is located in the upper thigh.
Phlebitis and thrombophlebitis of other sites The 2022 edition of ICD-10-CM I80. 8 became effective on October 1, 2021. This is the American ICD-10-CM version of I80.
Superficial venous thrombophlebitis of the great saphenous vein has been shown to be associated with thrombus propagation into the common femoral vein in up to 44% of cases. Conservative management can thus result in deep vein thrombosis, chronic venous insufficiency or fatal pulmonary embolism.
Patients who present with thrombosis of the great saphenous vein (GSV) or the small saphenous vein (SSV) should be considered for anticoagulation or ligation of the vein, given that a high incidence (6-44%) of concurrence or progression to DVT has been reported in such patients.
Thrombophlebitis (throm-boe-fluh-BY-tis) is an inflammatory process that causes a blood clot to form and block one or more veins, usually in the legs. The affected vein might be near the surface of the skin (superficial thrombophlebitis) or deep within a muscle (deep vein thrombosis, or DVT).
As it runs up the thigh, it remains on the medial side. The femoral triangle, at the top of the thigh and pelvis, is accessed by the great saphenous vein via an opening called the saphenous opening. It is here—at what's called the saphenofemoral junction—that it terminates into the femoral vein.
A saphenous vein is a vein in the leg that drains blood out of the leg and back to the heart. Each leg has a great saphenous vein, which travels along the front of the leg, and a small saphenous vein (also called the lesser saphenous vein), which travels along the back of the calf.
Acute embolism and thrombosis of superficial veins of right upper extremity. I82. 611 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM I82.
Superficial thrombophlebitis: If the vein that has the clot is just under the skin, it is called a superficial venous thrombosis or superficial thrombophlebitis. This type of clot does not usually travel to the lungs unless it reaches the deep veins.
ICD-10 code I80. 01 for Phlebitis and thrombophlebitis of superficial vessels of right lower extremity is a medical classification as listed by WHO under the range - Diseases of the circulatory system .
The ICD code I828 is used to code Paget-Schroetter disease. Paget–Schroetter disease, also known as Paget–von Schrötter disease, is a form of upper extremity deep vein thrombosis (DVT), a medical condition in which blood clots form in the deep veins of the arms.
I82.81. Non-Billable means the code is not sufficient justification for admission to an acute care hospital when used a principal diagnosis. Use a child code to capture more detail. ICD Code I82.81 is a non-billable code.
First, are the risk factors that are common for any venous thrombosis. Examples include thrombophilia, malignancy, age, immobility etc. There is evidence to suggest these factors are not rarely present in patients with saphenous vein thrombosis. A second group of risk factors are unique to saphenous vein thrombosis. Examples include post-ligation or post-EVLT. This is known as EHIT. Venous insufficiency is a risk factor for superficial vein thrombosis. However, when the thrombosis occurs outside of the varicose vein or in a vein in which there is no stagnant blood flow, other causes should be though of.
To date there is no clear recommendation as to the treatment of saphenous vein thrombosis. The latest ACCP guidelines suggests 45 days of prophylactic dose fondaparinux for ‘extensive’ lower extremity thrombosis. They are relying on the CALISTO study. One should note that the CALISTO investigators excluded many patients otherwise common in clinical practice such as patients with renal failure, malignancy, proven hypercoagulability and those with prior venous thromboembolism. Adequately, the level of this recommendation is quite weak. A 2012 mini-review published in the Annals of Internal Medicine echoed this finding pointing out that fondaparinux has to be given to 88 patients with saphenous vein thrombosis to prevent one deep vein thrombosis. A cheaper alternative may be low molecular weight heparin. However current data is confusing. The most problematic piece of information regarding low molecular weight heparin and saphenous vein thrombosis is that the deep vein thrombosis reducing effect may not be long-lived, as opposed to fondaparinux. On the other hand shorter duration of treatment was given. This data was again summarized without much change in a 2012 Cochrane database review of the matter.
Historically saphenous vein thrombosis was regarded as a benign condition. It was a disease treated by surgeons and encountered mainly in immobilized post-surgical patients. However there is data to suggest otherwise. Modern data suggests that saphenous vein thrombosis can propagate.
This is known as EHIT. Venous insufficiency is a risk factor for superficial vein thrombosis. However, when the thrombosis occurs outside of the varicose vein or in a vein in which there is no stagnant blood flow, other causes should be though of.
The great and small saphenous veins are considered superficial veins. Thus, saphenous vein thrombosis should be viewed as superficial vein thrombosis. However, if it extends near the sapheno-femoral junction, many argue that it should be treated as a deep clot. GSV thrombus ultrasound (V) with varicosities around it.
Thigh Ultrasound. Saphenous vein thrombosis is easily diagnosed but poses a therapeutic dilemma for clinicians. For some patients watchful waiting, warm compresses and NSAIDs are enough. But in highly symptomatic patinets, when clot is extensive and when clot is near the deep system, saphenous vein thrombosis should be treated with anticoagulation.
Modern data suggests that saphenous vein thrombosis can propagate. Furthermore, there is data to suggest that saphenous vein thrombosis actually commonly co-presents with deep vein thrombosis or even pulmonary embolism. These are most likely not rare occurrences and have been described as prevalent as 53%.